Genetic Studies for Cardiovascular Risk

This is a genetic risk assessment that allows establishing a person´s predisposition to suffer from cardiovascular diseases, using specialized detection tools.  These studies are always complementary to a complete medical evaluation.

Pre-symptomatic genetic testing (sometimes called cascade screening) is when the underlying gene change has been found in someone diagnosed with a condition, and his or her relatives choose to have a genetic test to know whether they are at risk of developing the condition in the future, even if they show no signs of it now. 

It is important to realize that predictive testing cannot tell whether a person will develop the inherited heart condition, or when.  If however a relative is found not to have the gene change they do not need to have ongoing follow up.